Cargando…

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

OBJECTIVES: The PIRADS Steering Committee has called for “higher quality data before making evidence-based recommendations on MRI without contrast enhancement as an initial diagnostic work up,” however, recognizing biparametric (bp) MRI as a reasonable option in a low-risk setting such as screening....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallström, Jonas, Geterud, Kjell, Kohestani, Kimia, Maier, Stephan E., Månsson, Marianne, Pihl, Carl-Gustaf, Socratous, Andreas, Arnsrud Godtman, Rebecka, Hellström, Mikael, Hugosson, Jonas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Urogenital
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523442/ https://www.ncbi.nlm.nih.gov/pubmed/33890152 http://dx.doi.org/10.1007/s00330-021-07907-9

Ejemplares similares

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate
por: Kohestani, Kimia, et al.
Publicado: (2021)

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial
por: Frånlund, Maria, et al.
Publicado: (2022)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

The primacy of multiparametric MRI in men with suspected prostate cancer
por: Richenberg, Jonathan, et al.
Publicado: (2019)

The longitudinal effect of ejaculation on seminal vesicle fluid volume and whole-prostate ADC as measured on prostate MRI
por: Barrett, Tristan, et al.
Publicado: (2017)

Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies
por: Schouten, Martijn G., et al.
Publicado: (2011)

3D T2-weighted imaging to shorten multiparametric prostate MRI protocols
por: Polanec, Stephan H., et al.
Publicado: (2017)

Optimising preoperative risk stratification tools for prostate cancer using mpMRI
por: Reisæter, Lars A. R., et al.
Publicado: (2017)

Simulated clinical deployment of fully automatic deep learning for clinical prostate MRI assessment
por: Schelb, Patrick, et al.
Publicado: (2020)

Prediction of prostate cancer grade using fractal analysis of perfusion MRI: retrospective proof-of-principle study
por: Michallek, Florian, et al.
Publicado: (2021)

Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
por: Vickers, Andrew J, et al.
Publicado: (2008)

MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance
por: Caglic, Iztok, et al.
Publicado: (2020)

Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
por: Giganti, Francesco, et al.
Publicado: (2020)

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017)

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?
por: Huebner, Nicolai Alexander, et al.
Publicado: (2020)

Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
por: Giganti, Francesco, et al.
Publicado: (2022)

Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
por: Giganti, Francesco, et al.
Publicado: (2019)

MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences
por: Bura, Vlad, et al.
Publicado: (2021)

Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2021)

Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features
por: Bernatz, Simon, et al.
Publicado: (2020)

ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training
por: de Rooij, Maarten, et al.
Publicado: (2020)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer
por: Axén, Elin, et al.
Publicado: (2021)

MRI of the kidney—state of the art
por: Nikken, J. J., et al.
Publicado: (2007)

Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases
por: Rud, Erik, et al.
Publicado: (2022)

Value of (68)Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [(18)F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study
por: Beheshti, Mohsen, et al.
Publicado: (2022)

ESUR prostate MR guidelines 2012
por: Barentsz, Jelle O., et al.
Publicado: (2012)

Structured reporting of pelvic MRI leads to better treatment planning of uterine leiomyomas
por: Sala, Evis, et al.
Publicado: (2018)

Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer
por: Wildeboer, Rogier R., et al.
Publicado: (2016)

Non-contrast MRI can accurately characterize adnexal masses: a retrospective study
por: Sahin, Hilal, et al.
Publicado: (2021)

MRI of female genital tract congenital anomalies: European Society of Urogenital Radiology (ESUR) guidelines
por: Maciel, Cristina, et al.
Publicado: (2020)

Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2023)

Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
por: Hole, Knut Håkon, et al.
Publicado: (2012)

The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program
por: da Silva, Miguel Correia, et al.
Publicado: (2022)

MRI as a tool to assess surgical margins and pseudocapsule features directly following partial nephrectomy for small renal masses
por: van Oostenbrugge, Tim J., et al.
Publicado: (2018)

Feasibility of a 2(nd) generation MR-compatible manipulator for transrectal prostate biopsy guidance
por: Bomers, J. G. R., et al.
Publicado: (2016)

Using MRI to differentiate upper-lateral intracavitary pregnancy and interstitial pregnancy for the patients with pregnancies in the uterotubal junction during the first trimester
por: Liu, Wenjuan, et al.
Publicado: (2022)

Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field
por: Watanabe, Masanaka, et al.
Publicado: (2022)

Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to reconsider scoring categorization?
por: Messina, Emanuele, et al.
Publicado: (2023)

Defining the incremental value of 3D T2-weighted imaging in the assessment of prostate cancer extracapsular extension
por: Caglic, Iztok, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ampjf2hnhhl23hlj01kf7f38r